Comment
doi: 10.1136/annrheumdis-2020-218075.
Epub 2020 Jun 26.
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
Affiliations
- PMID: 32591357
- DOI: 10.1136/annrheumdis-2020-218075
Item in Clipboard
Comment
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
Ann Rheum Dis.
2021 May.
No abstract available
Keywords: B-Lymphocytes; arthritis, rheumatoid; rituximab.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al.Ann Rheum Dis. 2021 May;80(5):e68. doi: 10.1136/annrheumdis-2020-218148. Epub 2020 Jun 26. Ann Rheum Dis. 2021. PMID: 32591359 No abstract available.
Comment on
-
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive _targeted therapies.Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241793 Free PMC article. No abstract available.
Similar articles
-
Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al.Ann Rheum Dis. 2021 May;80(5):e68. doi: 10.1136/annrheumdis-2020-218148. Epub 2020 Jun 26. Ann Rheum Dis. 2021. PMID: 32591359 No abstract available.
-
Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab.Immunol Res. 2021 Aug;69(4):309-311. doi: 10.1007/s12026-021-09212-5. Epub 2021 Jul 29. Immunol Res. 2021. PMID: 34324159 Free PMC article. No abstract available.
-
Prolonged Coronavirus Disease 2019 in a Patient With Rheumatoid Arthritis on Rituximab Therapy.J Infect Dis. 2021 Aug 2;224(3):557-559. doi: 10.1093/infdis/jiab248. J Infect Dis. 2021. PMID: 33964153 Free PMC article. No abstract available.
-
Efficacy and safety of rituximab in rheumatic diseases.Wien Med Wochenschr. 2015 Jan;165(1-2):28-35. doi: 10.1007/s10354-014-0331-8. Epub 2015 Jan 21. Wien Med Wochenschr. 2015. PMID: 25676699 Review.
-
Severe infection in patients with rheumatoid arthritis taking anakinra, rituximab, or abatacept: a systematic review of observational studies.Rev Bras Reumatol Engl Ed. 2016 Nov-Dec;56(6):543-550. doi: 10.1016/j.rbre.2016.10.001. Epub 2016 Oct 27. Rev Bras Reumatol Engl Ed. 2016. PMID: 27914602 Review. English, Portuguese.
Cited by
-
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature.Enferm Infecc Microbiol Clin (Engl Ed). 2022 Nov;40(9):507-516. doi: 10.1016/j.eimce.2021.01.009. Enferm Infecc Microbiol Clin (Engl Ed). 2022. PMID: 36336380 Free PMC article. Review.
-
Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases.RMD Open. 2022 Jan;8(1):e001898. doi: 10.1136/rmdopen-2021-001898. RMD Open. 2022. PMID: 34987093 Free PMC article.
-
Reply.Arthritis Rheumatol. 2022 May;74(5):909-910. doi: 10.1002/art.42012. Epub 2022 Mar 20. Arthritis Rheumatol. 2022. PMID: 34725969 Free PMC article. No abstract available.
-
B cell depletion impairs vaccination-induced CD8+ T cell responses in a type I interferon-dependent manner.Ann Rheum Dis. 2021 Dec;80(12):1537-1544. doi: 10.1136/annrheumdis-2021-220435. Epub 2021 Jul 5. Ann Rheum Dis. 2021. PMID: 34226189 Free PMC article.
-
Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy.J Clin Med. 2022 Mar 21;11(6):1739. doi: 10.3390/jcm11061739. J Clin Med. 2022. PMID: 35330069 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
